buspirone has been researched along with Colicky Pain in 6 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 9.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| " In this study performed on male Wistar rats, we used microelectrode recording of the caudal ventrolateral medulla (CVLM) neuron responses to colorectal distension (CRD) and electromyography recording of CRD-evoked visceromotor reactions (VMRs) to evaluate post-colitis changes in the effects of 5-HT1A agonist buspirone on supraspinal visceral nociceptive transmission." | 8.31 | Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats. ( Busygina, II; Lyubashina, OA; Sivachenko, IB; Sushkevich, BM, 2023) |
| "Using animal model of abdominal pain (urethane-anaesthetized rats), based on the noxious colorectal distension (CRD) as pain stimulus we studied effects of buspirone (1." | 7.88 | The central effects of buspirone on abdominal pain in rats. ( Lyubashina, OA; Panteleev, SS; Sivachenko, IB, 2018) |
| "Buspirone was eventually introduced." | 5.62 | Buspirone in the management of refractory irritable bowel syndrome: A case report. ( Al-Baz, N; Alabdulla, M; Haddad, PM; Karim, MA; Reagu, SM, 2021) |
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 5.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| " In this study performed on male Wistar rats, we used microelectrode recording of the caudal ventrolateral medulla (CVLM) neuron responses to colorectal distension (CRD) and electromyography recording of CRD-evoked visceromotor reactions (VMRs) to evaluate post-colitis changes in the effects of 5-HT1A agonist buspirone on supraspinal visceral nociceptive transmission." | 4.31 | Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats. ( Busygina, II; Lyubashina, OA; Sivachenko, IB; Sushkevich, BM, 2023) |
| "Using animal model of abdominal pain (urethane-anaesthetized rats), based on the noxious colorectal distension (CRD) as pain stimulus we studied effects of buspirone (1." | 3.88 | The central effects of buspirone on abdominal pain in rats. ( Lyubashina, OA; Panteleev, SS; Sivachenko, IB, 2018) |
| "Buspirone was eventually introduced." | 1.62 | Buspirone in the management of refractory irritable bowel syndrome: A case report. ( Al-Baz, N; Alabdulla, M; Haddad, PM; Karim, MA; Reagu, SM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Karim, MA | 1 |
| Al-Baz, N | 1 |
| Haddad, PM | 1 |
| Reagu, SM | 1 |
| Alabdulla, M | 1 |
| Lyubashina, OA | 4 |
| Sivachenko, IB | 3 |
| Sushkevich, BM | 1 |
| Busygina, II | 2 |
| Badihian, N | 1 |
| Yaghini, O | 1 |
| Badihian, S | 1 |
| Shahsanai, A | 1 |
| Saneian, H | 1 |
| Panteleev, SS | 3 |
| Nozdrachev, AD | 1 |
1 trial available for buspirone and Colicky Pain
| Article | Year |
|---|---|
Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial.
Topics: Abdominal Pain; Adolescent; Anxiety; Buspirone; Child; Depression; Female; Humans; Male; Pain Measur | 2020 |
5 other studies available for buspirone and Colicky Pain
| Article | Year |
|---|---|
Buspirone in the management of refractory irritable bowel syndrome: A case report.
Topics: Abdominal Pain; Adult; Buspirone; Humans; Irritable Bowel Syndrome; Male; Quality of Life; Serotonin | 2021 |
Opposing effects of 5-HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats.
Topics: Abdominal Pain; Animals; Buspirone; Colitis; Male; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; | 2023 |
The Buspirone-dependent Abdominal Pain Transmission Within the Nucleus Tractus Solitarius in the Rat.
Topics: Abdominal Pain; Animals; Buspirone; Humans; Neurons; Rats; Solitary Nucleus; Synaptic Transmission | 2021 |
Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs.
Topics: Abdominal Pain; Analgesics; Animals; Buspirone; Cardiovascular System; Disease Models, Animal; Dogs; | 2017 |
The central effects of buspirone on abdominal pain in rats.
Topics: Abdominal Pain; Animals; Buspirone; Medulla Oblongata; Neurons; Rats; Rats, Wistar; Serotonin Recept | 2018 |